Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente GUT

Tipo Año Título Fuente
Artículo2024Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver diseaseGUT
Artículo2023Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg)GUT
Artículo2023Empirical rescue treatment of Helicobacter pylori infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on H. pylori management (Hp-EuReg)GUT
Artículo2023Footprints of a microbial toxin from the gut microbiome to mesencephalic mitochondria.GUT
Artículo2023Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleedingGUT
Artículo2023Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosisGUT
Artículo2023Serum lipidome unravels a diagnostic potential in bile acid diarrhoea.GUT
Artículo2023Three double-dose reinforced hepatitis B revaccination scheme for patients with cirrhosis unresponsive to the standard regimen: an open-label randomised clinical trialGUT
Artículo2022Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?GUT
Artículo2022Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysisGUT
Artículo2022Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysisGUT
Letter2022Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomesGUT
Artículo2022Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical modelGUT
Artículo2021European Registry on Helicobacter pylori management (Hp-EuReg): Patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patientsGUT
Resumen congreso2019ALGORITHMS USING NONINVASIVE TESTS CAN ACCURATELY IDENTIFY PATIENTS WITH ADVANCED FIBROSIS DUE TO NASH: DATA FROM THE STELLAR CLINICAL TRIALSGUT
Resumen congreso2019ROUTINELY AVAILABLE NONINVASIVE TESTS DISCRIMINATE ADVANCED FIBROSIS DUE TO NASH IN THE PHASE 3 STELLAR TRIALS OF THE ASK1 INHIBITOR SELONSERTIBGUT
Artículo2017Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healingGUT
Artículo2017Role and therapeutic potential of vascular stem/progenitor cells in pathological neovascularisation during chronic portal hypertensionGUT
Artículo2012beta-catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cellsGUT
Artículo2011Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac diseaseGUT
Artículo2009Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patientsGUT
Póster2008Is fecal calprotectin useful in predicting disease relapse in patients with inflammatory bowel disease?GUT
Artículo2006Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexesGUT
Ponencia2005How accurate is fecal calprotectin in predecting an anormal colonoscopy?GUT
Artículo2004SLC11A1 promoter gene polymorphisms and fibrosis progression in chronic hepatitis CGUT
Letter2003Fatigue is associated with high circulating leptin levels in chronic hepatitis CGUT
Artículo2000TNF-alpha dependent production of inducible nitric oxide is involved in PGE(1) protection against acute liver injuryGUT
Ponencia1997Melatonin protects against NSAID-induced gastric injury in ratsGUT
Ponencia1997Preventive effect of zaprinast on NSAID-induced gastric injuryGUT